Evidence map›Paper›PMID 36458697›Full record

ArticleJournal of diabetes science and technology2023

Insulin Pumps and Hybrid Close Loop Systems Within Hospital: A Scoping Review and Practical Guidance From the Joint British Diabetes Societies for Inpatient Care.

Parizad Avari, Alistair Lumb, Daniel Flanagan, Gerry Rayman, Shivani Misra, Pratik Choudhary, Ketan Dhatariya

Open access · bronzeAbstract readScoping Review
In one paragraph

Article in Journal of diabetes science and technology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 3 pooled it
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 3 syntheses or guidelines pooled it, 31 citations in OpenAlex.

  1. [Hospital diabetes management (Update 2026)].Wiener klinische Wochenschrift · 2026
    Guideline
  2. Guideline
  3. Guideline
  4. Inpatient Use of Automated Insulin Delivery Systems.Journal of diabetes science and technology · 2026
    Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 1 country.

Parizad AvariDepartment of Diabetes and Endocrinology, Imperial College Healthcare NHS Trust, London, UK.ORCID 0000-0001-9047-3589
Alistair LumbOxford Centre for Diabetes, Endocrinology and Metabolism, Churchill Hospital, Oxford, UK.
Daniel FlanaganDepartment of Endocrinology, University Hospital Plymouth, Plymouth, UK.
Gerry RaymanIpswich Diabetes Centre, East Suffolk and North East Essex Foundation Trust, Ipswich, UK.ORCID 0000-0003-3331-7015
Shivani MisraDepartment of Metabolism, Digestion and Reproduction, Imperial College London, London, UK.
Pratik ChoudharyDiabetes Research Centre, University of Leicester, Leicester, UK.ORCID 0000-0001-7635-4735
Ketan DhatariyaElsie Bertram Diabetes Centre, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, UK.ORCID 0000-0003-3619-9579
Churchill Hospital · GBEast Suffolk and North Essex NHS Foundation Trust · GBImperial College Healthcare NHS Trust · GBImperial College London · GBNorfolk and Norwich University Hospitals NHS Foundation Trust · GBUniversity of Leicester · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This article is the second of a two-part series providing a scoping review and summary of the Joint British Diabetes Societies for Inpatient Care (JBDS-IP) guidelines on the use of diabetes technology in people with diabetes admitted to hospital. The first part reviewed the use of continuous glucose monitoring (CGM) in hospital. In this article, we focus on the use of continuous subcutaneous insulin infusion (CSII; insulin pumps) and hybrid closed-loop systems in hospital. JBDS-IP advocates enabling people who can self-manage and are willing and capable of using CSII to continue doing so as they would do out of hospital. CSII should be discontinued if the individual is critically ill or hemodynamically unstable. For individuals on hybrid closed-loop systems, the system should be discontinued from auto-mode, and may be used individually (as CGM only or CSII only, if criteria are met). Continuing in closed-loop mode may only be done so under specialist guidance from the Diabetes Team, where the diabetes teams are comfortable and knowledgeable about the specific devices used. Health care organizations need to have clear local policies and guidance to support individuals using these wearable technologies, and ensure the relevant workforce is capable and skilled enough to ensure their safe use within the hospital setting.

Indexed as

Diabetes Mellitus, Type 1Blood GlucoseBlood Glucose Self-MonitoringHospitalsHumansHypoglycemic AgentsInpatientsInsulinInsulin Infusion SystemsBlood GlucoseHypoglycemic AgentsInsulincontinuous subcutaneous insulin infusiondiabeteshybrid closed-loopinpatientinsulin pumpwearable technology

Identifiers

PMID36458697
PMCPMC10210119
OpenAlexW4310602905

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.